Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Pain 1

Interventions

pembrolizumab 18 Paclitaxel 15 Cisplatin 14 Carboplatin 13 Radiation 11 Nivolumab 10 Doxorubicin 10 Cyclophosphamide 10 Radiotherapy 9 Vincristine 8 Metformin 7 Fluorouracil 7 Etoposide 7 Cytarabine 7 tislelizumab 6 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 Leucovorin 6 Injections 6 Docetaxel 6 Bevacizumab 6 atezolizumab 5 Prednisone 5 Pemetrexed 5 Oxaliplatin 5 Methotrexate 5 Lenalidomide 5 Irinotecan 5 Ipilimumab 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Range of Motion, Articular × 30 days × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡